Drug
Tacrolimus
Tacrolimus: highest development phase Post-Market, developed by Astellas, Bayer, Takeda. 6 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Astellas, Bayer, Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tacrolimus NCT00177138 | Post-Market | Diabetes Mellitus |
| Tacrolimus NCT00885820 | Post-Market | Kidney Transplantation |
| tacrolimus NCT01316133 | Post-Market | Lupus Nephritis |
| Tacrolimus NCT01763580 | Post-Market | MCNS |
| tacrolimus ointment NCT00666159 | Post-Market | Dermatitis, Atopic |
| Tacrolimus NCT02954159 | Phase 3 | Ulcerative Colitis |
Latest
No recent events.
Follow Tacrolimus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.